Scpharmaceuticals Price Prediction
| SCPHDelisted Stock | USD 5.67 0.01 0.18% |
Momentum 64
Buy Extended
Oversold | Overbought |
Using Scpharmaceuticals hype-based prediction, you can estimate the value of Scpharmaceuticals from the perspective of Scpharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Scpharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Scpharmaceuticals because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Scpharmaceuticals after-hype prediction price | USD 5.67 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Scpharmaceuticals |
Scpharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Scpharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Scpharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Scpharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Scpharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Scpharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Scpharmaceuticals' historical news coverage. Scpharmaceuticals' after-hype downside and upside margins for the prediction period are 5.67 and 5.67, respectively. We have considered Scpharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Scpharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Scpharmaceuticals is based on 3 months time horizon.
Scpharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Scpharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Scpharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Scpharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 2 Events / Month | 5 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
5.67 | 5.67 | 0.00 |
|
Scpharmaceuticals Hype Timeline
Scpharmaceuticals is at this time traded for 5.67. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Scpharmaceuticals is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Scpharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 5.67. About 80.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.81. Scpharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in a few days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.Scpharmaceuticals Related Hype Analysis
Having access to credible news sources related to Scpharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Scpharmaceuticals' future price movements. Getting to know how Scpharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Scpharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CLYM | Climb Bio | 0.26 | 9 per month | 4.72 | 0.21 | 14.49 | (8.38) | 42.56 | |
| INZY | Inozyme Pharma | (0.32) | 1 per month | 3.27 | 0.15 | 10.42 | (7.26) | 179.17 | |
| CKPT | Checkpoint Therapeutics | 0.75 | 7 per month | 1.42 | 0.10 | 2.33 | (2.52) | 62.14 | |
| THRD | Third Harmonic Bio | 0.01 | 3 per month | 0.00 | (0.02) | 0.58 | (0.38) | 3.41 | |
| VIGL | Vigil Neuroscience | 0.01 | 8 per month | 1.63 | 0.12 | 5.09 | (2.49) | 241.38 | |
| ORTX | Orchard Therapeutics PLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SPPI | Spectrum Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LAB | Standard Biotools | (0.06) | 9 per month | 3.62 | 0.02 | 7.81 | (6.30) | 24.04 | |
| TSVT | 2Seventy Bio | (0.01) | 9 per month | 1.06 | 0.14 | 6.69 | (3.47) | 78.00 | |
| SLRN | ACELYRIN INC Common | (0.03) | 8 per month | 4.22 | 0.03 | 5.85 | (5.84) | 35.54 |
Scpharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Scpharmaceuticals price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Scpharmaceuticals using various technical indicators. When you analyze Scpharmaceuticals charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Scpharmaceuticals Predictive Indicators
The successful prediction of Scpharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Scpharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Scpharmaceuticals based on analysis of Scpharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Scpharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Scpharmaceuticals's related companies.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Scpharmaceuticals Stock
If you are still planning to invest in Scpharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scpharmaceuticals' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |